Cefuroxime Axetil

头孢呋辛酯

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCefuroxime Axetil
Drug Alias NameCefuroxima Axetil头孢呋新乙酰氧乙酯头孢呋新酯Cefuroximum Axetil头孢呋肟酯 +[14] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Cephalosporins antibiotics
Mechanisms of ActionBacterial penicillin-binding protein inhibitorsCell wall inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsAcute BronchitisUncomplicated skin and skin structure infectionsAcute bacterial skin and skin structure infections +[15] 
Global Approved IndicationsAcute BronchitisUncomplicated skin and skin structure infectionsOtitis Media +[14] 
Approved Indications in ChinaAcute BronchitisOtitis MediaUrinary Tract Infections +[7] 
Original Approved Country/TerritoryUnited States
Original Approved Date1987/12/28
Country/TerritoryUnited StatesMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline CorpSandoz
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsAcute BronchitisOtitis MediaUrinary Tract Infections +[10] 
Inactive IndicationsUncomplicated skin and skin structure infectionsAcute bacterial skin and skin structure infectionsImpetigo +[5] 

Other Information

ATC CodeJ01DC02S01AA27
Related LinksWikipediaDrugBankKEGG